Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 201 | -9,741 | -4,954 | -4,317 | -1,165 |
| Depreciation Amortization | 26 | 168 | 115 | 77 | 39 |
| Accounts receivable | 4,512 | -12,440 | -8,982 | -5,542 | -5,277 |
| Accounts payable and accrued liabilities | 1,646 | 1,394 | 2,625 | 2,700 | 2,039 |
| Other Working Capital | 1,215 | -14,833 | -5,735 | -7,280 | -4,070 |
| Other Operating Activity | -5,221 | 22,979 | 10,420 | 6,358 | 4,116 |
| Operating Cash Flow | $2,379 | $-12,473 | $-6,511 | $-8,004 | $-4,318 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -19,477 | N/A | N/A | N/A |
| Debt Repayment | N/A | -1,948 | N/A | N/A | N/A |
| Common Stock Issued | 1,323 | 44,239 | 1,985 | 186 | 371 |
| Other Financing Activity | -311 | -187 | -161 | -111 | -12 |
| Financing Cash Flow | $1,012 | $22,627 | $1,824 | $75 | $359 |
| Beginning Cash Position | 36,788 | 26,634 | 26,634 | 26,634 | 26,634 |
| End Cash Position | 40,179 | 36,788 | 21,947 | 18,705 | 22,675 |
| Net Cash Flow | $3,391 | $10,154 | $-4,687 | $-7,929 | $-3,959 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,379 | -12,473 | -6,511 | -8,004 | -4,318 |
| Free Cash Flow | 2,379 | -12,473 | -6,511 | -8,004 | -4,318 |